SOLIQUA 100/33 — SANOFI-AVENTIS US, approved 2026-03-12 (BLA208673).
2,658 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.